机构:[1]Capital Med Univ, Dept Neurol, Beijing Tiantan Hosp, Beijing 100050, Peoples R China;重点科室诊疗科室神经病学中心神经病学中心首都医科大学附属天坛医院[2]Chinese Med Assoc, Beijing Branch, Beijing 100050, Peoples R China;[3]Capital Med Univ, Grad Sch, Beijing 100050, Peoples R China
Background: We focus on the current resource level for UK/rt-PA therapy in hospitals in Beijing to design strategies for improving treatment for stroke patients. Methods: The data were collected through surveys of 124 grade 11 or higher hospitals in Bejing, which provide stroke treatment, from July to September 2006. Results: Of the surveyed hospitals, 50% and 92.6% were capable in providing intravenous UK/rt-PA treatment and head CT service, respectively. Eight (7.4%) hospitals have specialized stroke units and 106 (98.1%) hospitals have EDs. We found significant differences between hospitals that can provide UK/rt-PA therapy and the hospitals that cannot in the levels of specialists and clinical care capacity as follows: CT (100% vs 85.2%; P = 0.01), CTA (46.3% vs 22.2%; P = .014), MRI (66.7% vs 22.2%; P = .000), MRA (57.4% vs 20.4%; P = .000), DWI (48.1% vs 9.3%; P = .000), PWI (31.5% vs 5.6%; P = .001), DSA (63.0% vs 25.9%; P = .000), neurologists (100% vs 79.6%, P = .001), neurosurgeons (75.9% vs 44.4%: P = .002), carotid stenting (33.3% vs 5.6%; P = .000), stroke unit (14.8% vs 0%; P = .01), and acute stroke care system (31.5% vs 0%; P = .000). Conclusion: The thrombolysis treatment facilities in Beijing are not sufficient. Hospitals in Beijing should organize stroke-related medical sources. (C) 2009 Elsevier Inc. All rights reserved.
基金:
Beijing Municipal Science and Technology Commission Fund [D0905004040231]; 11.5th Key Technologies RD Programme [2006BAI01A11]
第一作者机构:[1]Capital Med Univ, Dept Neurol, Beijing Tiantan Hosp, Beijing 100050, Peoples R China;
通讯作者:
通讯机构:[1]Capital Med Univ, Dept Neurol, Beijing Tiantan Hosp, Beijing 100050, Peoples R China;
推荐引用方式(GB/T 7714):
Wang Yilong,Wu Di,Zhao Xingquan,et al.Hospital resources for urokinase/recombinant tissue-type plasminogen activator therapy for acute stroke in Beijing[J].SURGICAL NEUROLOGY.2009,72(SUPPL. 1):S2-S7.doi:10.1016/j.surneu.2007.12.028.
APA:
Wang, Yilong,Wu, Di,Zhao, Xingquan,Ma, Ruihua,Guo, Xiangping...&Wang, Yongjun.(2009).Hospital resources for urokinase/recombinant tissue-type plasminogen activator therapy for acute stroke in Beijing.SURGICAL NEUROLOGY,72,(SUPPL. 1)
MLA:
Wang, Yilong,et al."Hospital resources for urokinase/recombinant tissue-type plasminogen activator therapy for acute stroke in Beijing".SURGICAL NEUROLOGY 72..SUPPL. 1(2009):S2-S7